Pfizer Targets Wockhardt In Generic Toviaz Suit
Pfizer Inc. sued two units of rival Wockhardt Ltd. in Delaware federal court Friday, alleging its planned generic version of overactive-bladder medication Toviaz infringes a handful of patents covering the drug....To view the full article, register now.
Already a subscriber? Click here to view full article